Profiel
Peng Zhang is the founder of Zhongshan Kangfang Biopharma Co. Ltd.
(founded in 2012) and Akeso, Inc. (founded in 2012).
He holds the title of Chief Operating Officer & Vice President at Zhongshan Kangfang Biopharma Co. Ltd.
and Vice President at Akeso, Inc. Currently, he is an Independent Director at Hunan Warrant Pharmaceutical Co., Ltd.
(since 2022).
Dr. Zhang holds a doctorate degree from the University of Kentucky and an undergraduate degree from Shandong University.
Actieve functies van Peng Zhang
| Bedrijven | Functie | Begin |
|---|---|---|
| AKESO, INC. | Founder | 19-03-2012 |
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | Director/Board Member | 18-04-2022 |
Zhongshan Kangfang Biopharma Co. Ltd.
 Zhongshan Kangfang Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Zhongshan Kangfang Biopharma Co. Ltd. discovers and develops biologics with international intellectual rights for the treatment of a broad spectrum of diseases. The company was founded by Xia Yu, Baiyong Li, Peng Zhang and Max Wang in March 2012 and is headquartered in Zhongshan, China. | Founder | 01-03-2012 |
Opleiding van Peng Zhang
| University of Kentucky | Doctorate Degree |
| Shandong University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HUNAN WARRANT PHARMACEUTICAL CO.,LTD | Health Technology |
| AKESO, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Zhongshan Kangfang Biopharma Co. Ltd.
Zhongshan Kangfang Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Zhongshan Kangfang Biopharma Co. Ltd. discovers and develops biologics with international intellectual rights for the treatment of a broad spectrum of diseases. The company was founded by Xia Yu, Baiyong Li, Peng Zhang and Max Wang in March 2012 and is headquartered in Zhongshan, China. | Health Technology |
